The Patent Finder

Terms ending in 2039

Chemocentryx, Inc.

Every in-force patent on Chemocentryx, Inc.'s record whose computed term ends in 2039, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 11,154,556Methods of Treating Solid Tumors with CCR2 Antagonists
In force
 · High confidence
The Regents of the University of CaliforniaIn forceHigh confidence
US 11,207,294Methods of Treating Generalized Pustular Psoriasis with an Antagonist of CCR6 or CXCR2
In force
 · High confidence
Chemocentryx, Inc.In forceHigh confidence
US 11,684,606Methods of Treating Generalized Pustular Psoriasis with an Antagonist of CCR6 or CXCR2
In force
 · High confidence
Chemocentryx, Inc.In forceHigh confidence
US 12,758,558Methods of Treating Solid Tumors with CCR2 Antagonists
In force
 · High confidence
The Regents of the University of CaliforniaIn forceHigh confidence
US 10,568,874Indane-Amines as PD-L1 Antagonists
In force
 · High confidence
Chemocentryx, Inc.In forceHigh confidence
US 11,135,210Indane-Amines as PD-L1 Antagonists
In force
 · High confidence
Chemocentryx, Inc.In forceHigh confidence
US 11,759,458Indane-Amines as PD-L1 Antagonists
In force
 · High confidence
Chemocentryx, Inc.In forceHigh confidence
US 11,478,460DIARYL SUBSTITUTED 6,5-Fused RING COMPOUNDS AS C5aR INHIBITORS
In force
 · High confidence
Chemocentryx, Inc.In forceHigh confidence
US 12,268,675DIARYL SUBSTITUTED 6,5-Fused RING COMPOUNDS AS C5aR INHIBITORS
In force
 · High confidence
Chemocentryx, Inc.In forceHigh confidence
US 11,485,737DIARYL SUBSTITUTED 5,5-Fused RING COMPOUNDS AS C5aR INHIBITORS
In force
 · High confidence
Chemocentryx, Inc.In forceHigh confidence
8 more term ends in 2039 · Pro
10 of 18 patents shown. Soonest term end first, then patent number.
Pro members see all 18.
Upgrade to Pro
16 of these are in force and held by Chemocentryx, Inc..
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited